Papers

4

Total Citations

122

H-Index

4

About

No biography available yet.

Research Focus

Key Achievements

4
H-Index
4
Papers
122
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)
62 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Tianjin Medical University Cancer Institute and Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Not generated yet